Citation 88343

HUANG,JM: NAKADE,K: KONDO,M: YANG,CS: FUKUYAMA,Y:. (2002). BRINE SHRIMP LETHALITY TEST ACTIVE CONSTITUENTS AND NEW HIGHLY OXYGENATED SECO-PREZIZAANE-TYPE SESQUITERPENES FROM ILLICIUM MERRILLIANUM.. 50(1)

Citation Details

TitleBRINE SHRIMP LETHALITY TEST ACTIVE CONSTITUENTS AND NEW HIGHLY OXYGENATED SECO-PREZIZAANE-TYPE SESQUITERPENES FROM ILLICIUM MERRILLIANUM.
AuthorsHUANG,JM: NAKADE,K: KONDO,M: YANG,CS: FUKUYAMA,Y:
Year2002
Volume50
Issue1

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Illicium merrillianum (ILLICIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FOR
NoneNone
2
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
3
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
4Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
MERRILLIORTHOLACTONE
None
5
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
MERRILLIORTHOLACTONE
INACTIVE
6
NEURITE SPROUTING STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITRO
MERRILLIORTHOLACTONE
INACTIVE
7Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PARVIFLORALONE,2-ALPHA-HYDROXY:
None
8Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PARVIFLOROLIDE,2-ALPHA-HYDROXY:
None
9Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ANISATIN,2-ALPHA-HYDROXY:
None
10Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PALMITIC ACID METHYL ESTER
None
11
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PALMITIC ACID METHYL ESTER
INACTIVE
12Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CARYOPHYLLENE OXIDE
None
13
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CARYOPHYLLENE OXIDE
ACTIVE
14Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CADINOL,ALPHA: METHYL ETHER
None
15
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CADINOL,ALPHA: METHYL ETHER
ACTIVE
16Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
GERANIOL ACETATE
None
17
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
GERANIOL ACETATE
ACTIVE
18Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
HINOKININ,(-):
None
19
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
HINOKININ,(-):
ACTIVE
20Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
TASHIRONIN
None
21
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
TASHIRONIN
ACTIVE
22Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHENOL,4-ALLYL-2-6-DIMETHOXY:
None
23
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
PHENOL,4-ALLYL-2-6-DIMETHOXY:
INACTIVE
24Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CINNAMIC ACID,TRANS:
None
25
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CINNAMIC ACID,TRANS:
INACTIVE
26Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
KONGOL
None
27
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
KONGOL
ACTIVE
28Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
EUDESM-11-EN-4-ALPHA-OL,4-O-METHYL:
None
29
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
EUDESM-11-EN-4-ALPHA-OL,4-O-METHYL:
ACTIVE
30Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
OCTA-1-5-DIENE-3-7-DIOL,3-7-DIMETHYL:
None
31
ANTICRUSTACEAN ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
OCTA-1-5-DIENE-3-7-DIOL,3-7-DIMETHYL:
INACTIVE
Show SPARQL Queries (1)